Literature DB >> 33485867

Independent effects of 2hPG, FPG and HbA1c on cardiovascular risk: Analysis of a nationally representative sample from China.

Xiao Zhang1, Zuyao Yang2, Mei Zhang1, Yingying Zhu2, Zhenping Zhao1, Zhengjing Huang1, Chun Li1, Maigeng Zhou1, Andrew J Farmer3, Jinling Tang4, Limin Wang5.   

Abstract

AIMS: To evaluate the independence of the effect of 2-hour post-load plasma glucose (2hPG), fasting plasma glucose (FPG) and glycated hemoglobin (HbA1c) on cardiovascular disease (CVD) after adjusting for each other and non-glycemic factors.
METHODS: We analyzed data from a nationally representative sample of 174,329 Chinese adults from a survey conducted in 2013-2014. The associations of glycemic measures with the risk of CVD were examined and compared by using logistic regression analyses.
RESULTS: After adjusting for non-glycemic factors, the odds ratio for one standard-deviation increase of 2hPG, FPG and HbA1c was 1.08 (95% confidence interval [CI]: 1.05-1.11), 1.02 (95% CI: 0.99-1.06) and 1.05 (95% CI: 1.02-1.07), respectively. The odds ratio for 2hPG (1.10, 95% CI: 1.05-1.16) remained statistically significant after FPG and HbA1c were added to the models, whereas the odds ratios for FPG and HbA1c became statistically insignificant after 2hPG was adjusted for. The results remained consistent across various scenarios.
CONCLUSIONS: 2hPG showed an effect on cardiovascular risk which was independent from FPG and HbA1c, whereas whether the effects of FPG and HbA1c were independent from 2hPG was open to question. This finding calls for more research on how to better use FPG and HbA1c in diagnosing diabetes.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  2-hour post-load plasma glucose; Cardiovascular disease; Cross-sectional study; Fasting plasma glucose; Glycated hemoglobin; Glycemic measures

Mesh:

Substances:

Year:  2021        PMID: 33485867     DOI: 10.1016/j.diabres.2021.108672

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  2 in total

1.  Effect of liraglutide combined with metformin or acarbose on glucose control in type 2 diabetes mellitus and risk factors of gastrointestinal adverse reactions.

Authors:  Gaofei Ren; Xiaojun Ma; Pengfei Jiao
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

2.  The Value of Hemoglobin Glycation Index-Diabetes Mellitus System in Evaluating and Predicting Incident Stroke in the Chinese Population.

Authors:  Pengbo Wang; Qiyu Li; Xiaofan Guo; Ying Zhou; Zhao Li; Hongmei Yang; Shasha Yu; Yingxian Sun; Xingang Zhang
Journal:  J Clin Med       Date:  2022-09-30       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.